138 related articles for article (PubMed ID: 22051092)
1. Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population.
Pinto Neto LF; Ragi-Eis S; Vieira NF; Soprani M; Neves MB; Ribeiro-Rodrigues R; Miranda AE
J Clin Densitom; 2011; 14(4):434-9. PubMed ID: 22051092
[TBL] [Abstract][Full Text] [Related]
2. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of bone mineral density abnormalities and related risk factors in an ambulatory HIV clinic population.
Guillemi S; Harris M; Bondy GP; Ng F; Zhang W; Lima VD; Michaels CE; Belzberg A; Montaner JS
J Clin Densitom; 2010; 13(4):456-61. PubMed ID: 20663695
[TBL] [Abstract][Full Text] [Related]
4. Peripheral and central measurements of bone mineral density are equally strongly associated with clinical risk factors for osteoporosis.
Patel R; Blake GM; Fogelman I
Calcif Tissue Int; 2007 Feb; 80(2):89-96. PubMed ID: 17308990
[TBL] [Abstract][Full Text] [Related]
5. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
Seminari E; Castagna A; Soldarini A; Galli L; Fusetti G; Dorigatti F; Hasson H; Danise A; Guffanti M; Lazzarin A; Rubinacci A
HIV Med; 2005 May; 6(3):145-50. PubMed ID: 15876279
[TBL] [Abstract][Full Text] [Related]
6. Low bone mineral density among HIV-infected patients in Brazil.
Chaba DCDS; Soares LR; Pereira RMR; Rutherford GW; Assone T; Takayama L; Fonseca LAM; Duarte AJS; Casseb J
Rev Inst Med Trop Sao Paulo; 2017 Dec; 59():e89. PubMed ID: 29267597
[TBL] [Abstract][Full Text] [Related]
7. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
Conde FA; Sarna L; Oka RK; Vredevoe DL; Rettig MB; Aronson WJ
Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.
Schtscherbyna A; Pinheiro MF; Mendonça LM; Gouveia C; Luiz RR; Machado ES; Farias ML
Int J Infect Dis; 2012 Dec; 16(12):e872-8. PubMed ID: 23031418
[TBL] [Abstract][Full Text] [Related]
9. Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study.
Calmy A; Fux CA; Norris R; Vallier N; Delhumeau C; Samaras K; Hesse K; Hirschel B; Cooper DA; Carr A
J Infect Dis; 2009 Dec; 200(11):1746-54. PubMed ID: 19874178
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of low bone mineral density in Brazilian patients with systemic lupus erythematosus and its relationship with the disease damage index and other associated factors.
Souto MI; Coelho A; Guo C; Mendonça LM; Pinheiro MF; Papi JA; Farias ML
J Clin Densitom; 2012; 15(3):320-7. PubMed ID: 22321657
[TBL] [Abstract][Full Text] [Related]
11. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
Brown TT; Ruppe MD; Kassner R; Kumar P; Kehoe T; Dobs AS; Timpone J
J Clin Endocrinol Metab; 2004 Mar; 89(3):1200-6. PubMed ID: 15001610
[TBL] [Abstract][Full Text] [Related]
12. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
Mazzotta E; Ursini T; Agostinone A; Di Nicola AD; Polilli E; Sozio F; Vadini F; Pieri A; Trave F; De Francesco V; Capasso L; Borderi M; Manzoli L; Viale P; Parruti G
AIDS Patient Care STDS; 2015 Apr; 29(4):169-80. PubMed ID: 25692868
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
Compeyrot-Lacassagne S; Tyrrell PN; Atenafu E; Doria AS; Stephens D; Gilday D; Silverman ED
Arthritis Rheum; 2007 Jun; 56(6):1966-73. PubMed ID: 17530722
[TBL] [Abstract][Full Text] [Related]
15. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Carr A; Grund B; Neuhaus J; Schwartz A; Bernardino JI; White D; Badel-Faesen S; Avihingsanon A; Ensrud K; Hoy J;
HIV Med; 2015 Apr; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
[TBL] [Abstract][Full Text] [Related]
17. Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.
Tsai MS; Hung CC; Liu WC; Chen KL; Chen MY; Hsieh SM; Sheng WH; Sun HY; Shih TT
J Microbiol Immunol Infect; 2014 Apr; 47(2):109-15. PubMed ID: 23073318
[TBL] [Abstract][Full Text] [Related]
18. Low bone mass in human immunodeficiency virus-infected climacteric women receiving antiretroviral therapy: prevalence and associated factors.
Gomes DC; Valadares AL; de Moraes MJ; Lagrutta BB; Pinto-Neto AM; Costa-Paiva L
Menopause; 2015 Feb; 22(2):224-30. PubMed ID: 25003619
[TBL] [Abstract][Full Text] [Related]
19. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients.
Duvivier C; Kolta S; Assoumou L; Ghosn J; Rozenberg S; Murphy RL; Katlama C; Costagliola D;
AIDS; 2009 Apr; 23(7):817-24. PubMed ID: 19363330
[TBL] [Abstract][Full Text] [Related]
20. Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls.
Delpierre C; Bonnet E; Marion-Latard F; Aquilina C; Obadia M; Marchou B; Massip P; Perret B; Bernard J
J Clin Densitom; 2007; 10(4):376-80. PubMed ID: 17888698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
